revers
conjug
ubiquitin
ubiquitinlik
ubl
protein
protein
substrat
play
critic
role
regul
mani
cellular
pathway
remov
ubiquitin
target
protein
perform
ubiquitin
proteas
also
known
deubiquitylas
dub
owe
substrat
specif
central
role
ubiquityl
play
cell
signal
pathway
dub
attract
target
therapeut
develop
develop
dub
inhibitor
requir
assay
amen
highthroughput
screen
provid
rapid
assess
inhibitor
select
determin
inhibitor
select
earli
stage
drug
discoveri
reduc
drug
failur
clinic
well
reduc
overal
drug
develop
cost
develop
two
novel
assay
ublenterokinas
light
chain
ublgranzym
b
quantifi
ubiquitin
ubl
proteas
activ
quest
discov
character
novel
chemic
entiti
combin
assay
previous
develop
assay
multiplex
format
multiplex
format
allow
detect
three
distinct
proteas
activ
simultan
singl
well
demonstr
multiplex
format
abl
distinguish
select
nonselect
proteas
inhibitor
specif
use
assay
format
character
select
ubiquitinspecif
proteas
inhibitor
discov
progenra
biquitin
small
protein
coval
conjug
specif
lysin
residu
target
protein
therebi
regul
target
protein
function
local
stabil
addit
ubiquitin
sever
ubiquitinlik
ubl
protein
describ
sumo
small
ubiquitinlik
modif
found
member
ubl
protein
famili
other
includ
interferon
stimul
gene
neural
precursor
cell
express
development
downregul
protein
revers
conjug
ubiquitin
ubl
protein
target
protein
regul
plethora
cellular
process
protein
util
similar
enzymat
process
conjug
target
protein
respect
ubiquitin
ctermin
glycin
residu
matur
ubiquitin
protein
conjug
eaminogroup
lysin
residu
via
multistep
multienzym
pathway
result
attach
singl
ubiquitin
moieti
target
protein
refer
monoubiquityl
monoubiquityl
target
protein
alter
function
andor
local
addit
ubiquitin
attach
first
ubiquitin
form
polyubiquitin
chain
chain
form
via
sever
lysin
residu
present
ubiquitin
extens
polyubiquitin
chain
lysin
ubiquitin
observ
cell
best
character
polyubiquitin
chain
built
via
lysin
ubiquitin
lysin
chain
target
protein
degrad
ubiquitin
proteasom
exact
function
variou
chain
target
protein
area
intens
interest
recent
research
suggest
chain
lysin
may
also
target
protein
degrad
interestingli
ubl
protein
sumo
demonstr
form
chain
vivo
sumoyl
protein
target
protein
degrad
function
primarili
regul
activ
local
protein
notabl
transcript
factor
neddyl
protein
regul
activ
substrat
essenti
activ
scf
famili
ubiquitin
ligas
exemplifi
interact
among
variou
ubiquitinubl
pathway
conjug
ubiquitin
ubl
protein
revers
famili
proteas
collect
refer
deubiquitylas
dub
famili
enzym
subdivid
five
class
ubiquitin
ctermin
hydrolas
ubiquitinspecif
proteas
usp
jamm
motif
metalloproteas
machadojosephin
domain
contain
proteas
ovarian
tumor
relat
domain
contain
proteas
proteas
bioinformat
analysi
human
genom
identifi
gene
encod
dub
dysregul
isopeptidas
link
varieti
diseas
state
clear
dub
activ
respons
regul
mani
vital
cell
function
addit
research
begun
identifi
viral
bacteri
protein
cleav
ubiquitin
ubiquityl
protein
mani
enzym
direct
impact
viabil
andor
virul
pathogen
agent
reason
grow
effort
target
enzym
therapeut
develop
discoveri
character
select
isopeptidas
inhibitor
requir
robust
assay
system
quantifi
enzym
activ
rapidli
character
inhibitor
current
assay
dub
activ
employ
hydrolysi
small
molecul
adduct
coumarin
rhodamin
cterminu
ubiquitin
lead
increas
fluoresc
howev
dub
recogn
polyor
monoubiquityl
protein
complex
small
molecul
attach
cterminu
ubiquitin
ubl
address
dispar
develop
novel
assay
featur
ubiquitin
attach
via
peptid
bond
enzym
render
enzym
inact
specif
hydrolysi
proteinubiquitin
bond
enzym
activ
previous
report
assay
base
upon
fusion
ubiquitin
nterminu
phospholipas
pla
technolog
extend
scope
describ
two
novel
assay
platform
measur
enzymat
activ
ubiquitinubl
proteas
assay
involv
fusion
ubiquitin
ubl
nterminu
enterokinas
light
chain
ek
l
granzym
b
gzmb
newli
develop
report
offer
number
benefit
exampl
l
fusion
protein
effici
cleav
subpicomolar
concentr
moreov
assay
combin
ubiquitinpla
report
system
multiplex
format
allow
us
rapidli
determin
substrat
specif
dub
specif
discov
cleav
ubiquitin
conjug
vitro
addit
use
multiplex
enzym
format
character
two
novel
isopeptidas
inhibitor
novel
report
system
play
import
role
character
ubiquitinubl
isopeptidas
develop
select
isopeptidas
inhibitor
potenti
therapeut
agent
chemic
purchas
sigma
st
loui
mo
unless
otherwis
note
tetrapeptid
isolevcineglutam
acidprolineaspart
acid
iepd
amc
purchas
emd
bioscienc
san
diego
ca
prepar
dimethyl
sulfoxid
dmso
amino
nbd
c
hpc
purchas
invitrogen
carlsbad
ca
prepar
ethanol
purchas
lifesensor
malvern
pa
prepar
dmso
sulfon
vs
purchas
boston
biochem
boston
chromatographi
column
media
purchas
ge
healthscienc
piscataway
nj
analog
ek
l
substrat
ii
procur
anaspec
fremont
ca
ubiquitinpla
catalyt
domain
deneddylas
plpro
prepar
previous
describ
bacteri
express
plasmid
encod
hexahistag
fusion
ubiquitinubl
activ
fragment
ek
l
gener
standard
molecular
biolog
techniqu
primer
list
supplementari
figur
supplementari
data
avail
onlin
wwwliebertonlinecom
adt
ubiquitinublek
l
report
fusion
protein
express
purifi
use
method
similar
previous
describ
ek
l
fusion
gzmb
gener
vector
lifesensor
use
standard
molecular
biolog
techniqu
stabl
pichia
pustori
transform
gener
accord
manufactur
instruct
six
isol
clone
evalu
express
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
western
blot
use
antigzmb
abd
serotec
oxford
unit
kingdom
scaleup
product
accomplish
inocul
ml
bmgi
od
reach
cultur
centrifug
resuspend
ml
bmmi
grown
shake
rpm
h
cultur
supplement
methanol
h
supernat
extens
dialyz
phosphatebuff
salin
purifi
nickel
chromatographi
use
standard
techniqu
ublek
l
assay
unless
state
otherwis
recombin
isopeptidas
mix
ublek
l
ek
l
substrat
final
concentr
nm
respect
total
volum
ml
well
blackwal
plate
greiner
bioon
monro
nc
dilut
perform
isopeptidas
assay
buffer
mm
trishcl
ph
mm
cacl
mm
bmercaptoethanol
increas
fluoresc
intens
time
determin
perkin
elmer
envis
fluoresc
plate
reader
excit
emiss
filter
correspond
fluoresc
reson
energi
transfer
peptid
util
unless
state
otherwis
net
rel
fluoresc
unit
rfu
determin
subtract
blank
rfu
valu
nm
ek
l
substrat
nm
ek
l
substrat
ii
isopeptidas
assay
buffer
data
point
l
sensit
experi
perform
mix
fm
nm
l
nm
ek
l
substrat
total
volum
ml
assay
unless
state
otherwis
recombin
isopeptidas
mix
iepdamc
final
concentr
nm
nm
mm
respect
total
volum
ml
well
blackwal
plate
greiner
bioon
dilut
perform
isopeptidas
assay
buffer
mm
trishcl
ph
mm
cacl
mm
bmercaptoethanol
increas
fluoresc
intens
time
determin
perkin
elmer
envis
fluoresc
plate
reader
excit
emiss
maxima
nm
respect
unless
state
otherwis
net
rfu
determin
subtract
blank
rfu
valu
mm
iepdamc
isopeptidas
assay
buffer
data
point
concentr
depend
experi
perform
mix
nm
core
nm
mm
iepdamc
total
volum
ml
gener
multiplex
assay
includ
nm
mm
iepdamc
nm
ubiquitinpla
mm
nbd
c
hpc
nm
l
mm
ek
l
substrat
ii
case
l
replac
l
fluoresc
measur
follow
pair
wavelength
report
desumoylas
dub
deisgylas
activ
respect
signal
nois
ratio
snr
calcul
follow
equat
rfu
enzym
rfu
minu
enzym
stddev
enzym
stddev
minu
enzym
z
valu
calcul
signal
background
calcul
rfu
enzym
rfu
minu
enzym
dose
rang
isopeptid
inhibitor
prepar
dmso
ml
aliquot
ad
plate
triplic
eighti
microlit
isopeptidas
ad
well
individu
mixtur
three
enzym
incub
room
temperatur
min
ml
reporterfus
report
substrat
ad
well
final
concentr
mm
nethylmaleimid
nem
vv
dmso
use
control
inhibit
percent
inhibit
calcul
use
follow
equat
rfu
compound
l
rfu
nem
rfu
dmso
rfu
nem
data
plot
prism
ic
valu
determin
use
sigmoid
doserespons
variabl
slope
model
previous
report
develop
novel
ubiquitinubl
endopeptidas
assay
util
linear
fusion
ubiquitinubl
nterminu
pla
pla
requir
free
nterminu
activ
fusion
ubiquitinubl
nterminu
result
inactiv
enzym
incub
ubiquitinubl
isopeptidas
result
cleavag
apeptid
bond
ubiquitinubl
pla
result
activ
pla
measur
use
quench
fluoresc
substrat
pla
addit
pla
ek
l
gzmb
requir
free
nterminu
enzymat
activ
gener
plasmid
encod
fuse
nterminu
activ
form
ek
l
gzmb
express
purifi
fusion
protein
predict
fusion
protein
catalyt
inact
determin
fusion
could
cleav
isopeptidas
incub
core
catalyt
domain
desumoylas
upon
activ
ek
l
cleav
intern
quench
fluoresc
reson
energi
transfer
peptid
result
increas
fluoresc
shown
figur
incub
l
ek
l
substrat
result
dramat
increas
fluoresc
due
mediat
cleavag
apeptid
bond
ek
l
similar
manner
incub
result
activ
gzmb
cleav
substrat
iepdamc
lead
releas
amc
fluorophor
concomit
increas
amc
fluoresc
case
rate
fluoresc
increas
depend
concentr
demonstr
assay
use
quantifi
desumoylas
activ
l
system
reach
plateau
within
time
frame
assay
wherea
signal
remain
linear
throughout
cours
experi
like
caus
differ
amount
report
substrat
use
assay
ek
l
substrat
present
nm
wherea
gzmb
substrat
present
mm
given
high
sensit
l
report
system
fig
investig
minim
concentr
core
assay
could
reliabl
detect
incub
subpicomolar
dose
rang
l
ek
l
substrat
measur
chang
fluoresc
h
figur
demonstr
l
assay
exhibit
signific
increas
signal
concentr
low
subsequ
prepar
linear
fusion
protein
consist
altern
ubiquitinubl
protein
fuse
nterminu
ek
l
includ
ubiquitin
fusion
could
activ
incub
proteas
recogn
cognat
ubiquitinubl
supplementari
fig
taken
togeth
data
indic
ublek
l
suitabl
report
measur
proteas
activ
gener
multipl
ubiquitinubl
proteas
report
system
allow
us
investig
potenti
combin
assay
use
multiplex
format
fig
due
spectral
overlap
ek
l
substrat
pla
substrat
nbd
c
hpc
switch
altern
substrat
ek
l
ek
l
substrat
ii
excit
emiss
maxima
nm
respect
lack
spectral
overlap
fluorophor
util
shown
supplementari
figur
demonstr
report
system
could
measur
simultan
singl
well
optim
concentr
assay
compon
yield
high
snr
isopeptidas
report
combin
data
shown
subsequ
combin
nm
report
ubiquitinpla
l
appropri
concentr
substrat
fig
three
ubl
isopeptidas
ad
increas
fluoresc
intens
observ
correspond
activ
report
substrat
verifi
signal
depend
upon
presenc
cognat
isopeptidas
repeat
experi
includ
addit
complet
reaction
contain
three
ubiquitin
isopeptidas
control
lack
one
isopeptidas
fig
figur
show
signal
gener
l
complet
depend
presenc
similar
result
obtain
omit
isopeptidas
fig
valid
system
highthroughput
screen
ht
calcul
snr
z
valu
report
system
multiplex
format
report
yield
z
snr
indic
assay
format
robust
reproduc
fig
confirm
addit
combin
report
useabl
ht
multiplex
format
also
valid
multiplex
format
util
ubiquitinpla
l
data
shown
predict
addit
combin
report
system
possibl
depend
experiment
design
avail
suitabl
substrat
bioinformat
analysi
success
identifi
mani
gene
predict
express
ubiquitin
ubl
isopeptidas
character
substrat
specif
novel
isopeptidas
import
first
step
determin
physiolog
role
proteas
alreadi
demonstr
gener
signal
cognat
ubl
ubiquitin
respect
effort
character
usp
class
enzym
express
purifi
test
activ
nm
ubiquitinpla
l
respect
substrat
report
enzym
multiplex
format
standard
purpos
includ
control
isopeptidas
report
set
signal
gener
control
isopeptidas
control
isopeptidas
concentr
select
base
similar
rate
increas
fluoresc
intens
thu
standard
assay
differ
ubl
expect
exhibit
robust
signal
ubiquitinpla
neglig
activ
fig
howev
addit
dub
activ
also
exhibit
modest
deisgylas
activ
fig
demonstr
util
multiplex
assay
format
rapidli
discov
novel
substrat
specif
isopeptidas
confirm
result
incub
increas
concentr
l
ek
l
substrat
observ
dose
depend
increas
activ
fig
taken
togeth
data
report
novel
deisgylas
activ
demonstr
multiplex
assay
format
use
determin
substrat
select
ubiquitinubl
proteas
ubiquitin
isopeptidas
potenti
target
therapeut
intervent
identifi
develop
isopeptidas
inhibitor
necessari
rapidli
screen
novel
chemic
entiti
versu
sever
relat
enzym
multiplex
assay
format
describ
would
predict
acceler
screen
character
novel
chemic
entiti
allow
scientist
test
effect
multipl
enzym
simultan
test
hypothesi
studi
two
small
molecul
isopeptidas
inhibitor
broadli
activ
ubiquitin
ubl
isopeptidas
inhibitor
analog
recent
discov
inhibitor
addit
test
select
deneddylas
activitybas
probe
probe
coval
modifi
activ
site
cystein
residu
deneddylas
render
enzym
inact
initi
determin
ic
compound
versu
individu
tabl
subsequ
dose
rang
preincub
simultan
addit
three
report
substrat
measur
enzym
activ
fig
experi
clear
nonselect
isopeptidas
inhibitor
ic
valu
rang
mm
three
enzym
test
contrast
select
inhibit
singleplex
multiplex
format
tabl
seen
figur
neglig
activ
versu
concentr
rang
test
inhibit
ic
mm
comparison
singleplex
multiplex
data
tabl
clearli
demonstr
multiplex
format
dramat
alter
ic
valu
select
inhibitor
valid
use
multiplex
format
character
isopeptidas
inhibitor
rapidli
expand
field
ubiquitin
research
requir
develop
novel
technolog
enabl
research
effici
deciph
physiolog
function
regulatori
enzym
pathway
ubiquitin
ubl
isopeptidas
key
regul
multipl
cellular
signal
cascad
repres
novel
class
target
therapeut
develop
describ
two
new
report
system
ublek
l
ublgzmb
report
fusion
effici
cleav
ubiquitin
ubl
proteas
use
quantifi
activ
addit
select
report
enzym
substrat
gener
fluoresc
signal
nonoverlap
discreet
wavelength
rang
one
combin
ublpla
report
system
multiplex
format
multiplex
format
afford
measur
three
distinct
proteas
activ
simultan
singl
well
demonstr
util
multiplex
enzym
assay
character
enzym
specif
addit
confirm
dub
simultan
uncov
previous
unreport
deisgylas
activ
enzym
date
one
mammalian
isopeptidas
shown
function
deisgylas
multiplex
format
abl
measur
activ
three
report
singl
well
three
isopeptidas
ad
l
well
contain
gzmb
substrat
pla
substrat
ek
l
substrat
ii
pla
phospholipas
color
imag
avail
onlin
wwwliebertonlinecomadt
determin
absolut
catalyt
effici
isopeptidas
addit
studi
need
fulli
character
activ
howev
clear
multiplex
format
facilit
rapid
initi
character
novel
ubiquitinubl
proteas
therapeut
potenti
target
ubiquitinubl
pathway
establish
fda
approv
ubiquitin
proteasom
inhibitor
bortezomibvelcad
treatment
multipl
myeloma
recent
millennium
develop
select
activ
enzym
inhibitor
prevent
conjug
scf
ligas
inhibitor
current
develop
novel
cancer
therapeut
addit
target
ubiquitin
ubl
isopeptidas
consid
potenti
drug
target
one
major
concern
develop
isopeptidas
inhibitor
select
within
proteas
famili
case
ubiquitin
isopeptidas
advantag
determin
select
inhibitor
earli
stage
rapidli
exclud
nonselect
inhibitor
develop
process
address
issu
fig
detect
ubiquitinubiquitinlik
proteas
activ
multiplex
assay
format
ubiquitinpla
l
incub
either
complet
mixtur
contain
mixtur
lack
one
three
isopeptidas
fluoresc
intens
measur
follow
incub
signal
background
calcul
repres
data
one
three
independ
experi
shown
bar
repres
signal
background
gener
report
solid
bar
ubiquitinpla
report
open
bar
l
report
crosshatch
bar
b
cocktail
isopeptidas
contain
close
circl
without
open
circl
ad
well
contain
iepdamc
ubiquitinpla
nbd
c
hpc
l
ek
l
substrat
ii
fluoresc
intens
measur
describ
materi
method
section
error
bar
repres
standard
error
n
valu
c
util
data
b
signal
nois
ratio
solid
bar
z
ratio
open
bar
calcul
describ
materi
method
data
shown
averag
three
independ
experi
error
bar
repres
standard
error
three
valu
nbd
c
hpc
amino
usp
ubiquitinspecif
proteas
establish
multiplex
assay
format
allow
simultan
measur
proteas
activ
three
distinct
isopeptidas
employ
multiplex
format
character
select
ubiquitinubl
isopeptidas
inhibitor
singleplex
multiplex
format
report
potenc
inhibitor
tabl
multiplex
assay
format
amen
ht
provid
research
initi
determin
inhibitor
select
primari
screen
compound
librari
like
approach
speed
discoveri
select
ubiquitinubl
isopeptidas
inhibitor
develop
potenti
therapeut
fig
deisgylas
well
deubiquitylas
nm
incub
nm
mm
iepdamc
nm
ubiquitinpla
nbd
c
hpc
nm
l
mm
ek
l
substrat
ii
fluoresc
intens
measur
incub
desumoylas
deubiquitylas
deisgylas
activ
report
rel
control
desumoylas
nm
core
deubiquitylas
nm
deisgylas
nm
plpro
activ
respect
solid
bar
signal
gener
repres
open
bar
repres
data
three
independ
experi
shown
ic
valu
mm
four
inhibitor
three
ubiquitinubl
isopeptidas
determin
either
singleplex
multiplex
assay
format
nem
broadspectrum
cystein
proteas
inhibitor
wherea
select
deneddylas
inhibitor
respect
data
repres
mean
standard
deviat
three
independ
experi
nem
nethylmaleimid
ubl
ubiquitinlik
usp
ubiquitinspecif
proteas
vs
vinyl
sulfon
agent
well
tool
compound
studi
biolog
signific
particular
proteas
select
inhibitor
test
